E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/12/2013 in the Prospect News PIPE Daily.

MusclePharm sells $2.5 million of its stock via private placement

Company sells 238,096 common shares at $10.50 per share in offering

By Devika Patel

Knoxville, Tenn., Aug. 12 - MusclePharm Corp. said it completed a $2.5 million private placement of stock. The Frost Group, LLC was the lead investor.

The company sold 238,096 restricted common shares at $10.50 per share. The price per share reflects a 14.98% discount to the Aug. 9 closing share price of $12.35.

MusclePharm develops sports nutrition products and is based in Denver.

Issuer:MusclePharm Corp.
Issue:Restricted common stock
Amount:$2.5 million
Shares:238,096
Price:$10.50
Warrants:No
Investor:The Frost Group, LLC (lead)
Settlement date:Aug. 12
Stock symbol:OTCBB: MSLP
Stock price:$12.35 at close Aug. 9
Market capitalization:$90.63 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.